Published in Vaccine Weekly, October 18th, 1999
And in another large trial, the vaccine protected against acute otitis media (AOM) caused by vaccine-specific bacteria.
The vaccine is less reactogenic than the universally recommended DTP/Hib combination vaccine but more reactogenic than hepatitis B virus (HBV) vaccine.
"This heptavalent pneumococcal conjugate vaccine appears to be highly effective in preventing invasive disease and pneumonia in young children and to have a significant impact on otitis media as well," said Steven Black of the Kaiser Permanente Vaccine Study Center,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1999-10-18)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.